PharmaShots | Incisive News in 3 Shots

Subscribe Now

Biotheryx

Biotheryx Receives the US FDA’s IND Approval of BTX-9341 for Treating Breast Cancer

Biotheryx Receives the US FDA’s IND Approval of BTX-9341 for Treating Breast Cancer

May 8, 2024

Biotheryx Entered into a Research Collaboration and License agreement with Incyte to Discover and Develop Targeted Protein Degraders

Biotheryx Entered into a Research Collaboration and License agreement with Incyte to Discover and Develop Targeted Protein Degrade...

April 6, 2023

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us